Related references
Note: Only part of the references are listed.Novel function for the p38-MK2 signaling pathway in circulating CD1c+(BDCA-1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL-12 whilst suppressing IL-10
Hester A. Franks et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect
Alexander Shimabukuro-Vornhagen et al.
CELLULAR IMMUNOLOGY (2013)
Dendritic Cell Vaccine for Recurrent High-Grade Gliomas in Pediatric and Adult Subjects: Clinical Trial Protocol
Ashish H. Shah et al.
NEUROSURGERY (2013)
Immunotherapy of Cancer with 4-1BB
Dass S. Vinay et al.
MOLECULAR CANCER THERAPEUTICS (2012)
An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma
Sara Nava et al.
PLOS ONE (2012)
Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies
Paolo A. Ascierto et al.
SEMINARS IN ONCOLOGY (2010)
The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer
Hae-Young Yong et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
IL-2-and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets
Sven Letourneau et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma
Wim Maes et al.
NEURO-ONCOLOGY (2009)
Expression of CD4 on Epstein-Barr Virus-immortalized B Cells
C. Hoennscheidt et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
Steven De Vleeschouwer et al.
CLINICAL CANCER RESEARCH (2008)
The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma
Atsushi Natsume et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Loss of detectability of Charcot-Leyden crystal protein transcripts in blood cells after treatment with dimethyl sulfoxide
Juergen L. Foell et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics
Andrew G. Jarnicki et al.
JOURNAL OF IMMUNOLOGY (2008)
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation:: enhanced T cell stimulatory capacity despite IDO
Petra Krause et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells
Henric S. Adler et al.
BLOOD (2007)
Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease
Onur Boyman et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
ERK and p38 MAPK signaling pathways negatively regulate CIITA gene expression in dendritic cells and macrophages
Yongxue Yao et al.
JOURNAL OF IMMUNOLOGY (2006)
Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma
SQ Wang et al.
BLOOD (2006)
The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells
Francis Dodeller et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor
H Nishimoto et al.
BLOOD (2005)
Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: Increased durable cellular immunity with reduced immunodominance
AC Moore et al.
JOURNAL OF IMMUNOLOGY (2005)
The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells
F Dodeller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma
DP Xu et al.
GENE THERAPY (2005)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
LM Liau et al.
CLINICAL CANCER RESEARCH (2005)
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
R Yamanaka et al.
CLINICAL CANCER RESEARCH (2005)
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3
JD Fontenot et al.
NATURE IMMUNOLOGY (2005)
Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells
S De Vleeschouwer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
p38 mitogen-activated protein kinase mediates dual role of ultraviolet B radiation in induction of maturation and apoptosis of monocyte-derived dendritic cells
S Nakagawa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines
F Ito et al.
CANCER RESEARCH (2004)
Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12
T Kikuchi et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
R Yamanaka et al.
BRITISH JOURNAL OF CANCER (2003)
Thymic CD8(+) T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality
CJ Wheeler et al.
JOURNAL OF IMMUNOLOGY (2003)
Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: Involvement of mitogen-activated protein kinase p38
J Xie et al.
JOURNAL OF IMMUNOLOGY (2003)
4-1BB co-stimulation enhances human CD8+ T cell priming by augmenting the proliferation and survival of effector CD8+ T cells
D Laderach et al.
INTERNATIONAL IMMUNOLOGY (2002)
Cutting edge: expression of functional CD137 receptor by dendritic cells
RA Wilcox et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells
T Futagawa et al.
INTERNATIONAL IMMUNOLOGY (2002)
Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells
A Puig-Kröger et al.
BLOOD (2001)
Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
T Kikuchi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
Dendritic cells: Specialized and regulated antigen processing machines
I Mellman et al.
CELL (2001)
4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy
JL Cannons et al.
JOURNAL OF IMMUNOLOGY (2001)
The generation of anti-tumoral cells using dendritic cells from the peripheral blood of patients with malignant brain tumors
S Yoshida et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
A critical pole for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers
JF Arrighi et al.
JOURNAL OF IMMUNOLOGY (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response
JL Cannons et al.
JOURNAL OF IMMUNOLOGY (2000)
Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma
SE Strome et al.
JOURNAL OF IMMUNOTHERAPY (2000)
p38 MAP kinases: beyond the stress response
AR Nebreda et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8+ but not CD4+ T cells
C Merritt et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Consequences of antigen self-presentation by tumor-specific cytotoxic T cells
MS Staege et al.
IMMUNOBIOLOGY (2000)
Share Paper
